FDA Inspection
Changzhou Sunlight Pharmaceutical Co., Ltd.Changzhou Sunlight Pharmaceutical Co., Ltd. – FDA Inspection, Sep 22, 2017
Record Details
This FDA Inspection record concerns Changzhou Sunlight Pharmaceutical Co., Ltd., with an inspection on September 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 22, 2017
- Product Type
- Drugs
View Company Profile
ID · dad699da-6d0a-4299-8f5e-32f745c48c5b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1028201
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Changzhou Sunlight Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Changzhou Sunlight Pharmaceutical Co., Ltd.
- FDA Inspection 1244728 - 2024-05-31
- FDA Inspection 925759 - 2015-04-10
- FDA Inspection 733768 - 2011-07-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.